Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2026-04-12 @ 7:19 PM
Study NCT ID:
NCT01989468
Status:
COMPLETED
Last Update Posted:
2019-04-16
First Post:
2013-11-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-04-10
Start Date Type:
ACTUAL
Primary Completion Date:
2015-05-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03-28
Completion Date Type:
ACTUAL
First Submit Date:
2013-11-07
First Submit QC Date:
None
Study First Post Date:
2013-11-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-02-25
Results First Submit QC Date:
None
Results First Post Date:
2019-04-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-15
Last Update Post Date:
2019-04-16
Last Update Post Date Type:
ACTUAL